No effects of probiotics on atopic dermatitis in infancy: a randomized placebo-controlled trial

M L Brouwer1, S A A Wolt-Plompen, A E J Dubois

  • 1Department of Paediatrics, Division of Paediatric Pulmonology, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. m.l.brouwer@bkk.umbg

Insights

Probiotic supplementation did not significantly improve atopic dermatitis (AD) symptoms or immunological markers in infants. This study found no clinical benefit of using these specific probiotic strains for infantile AD.

Area of Science:

  • Immunology
  • Pediatrics
  • Microbiology

Background:

  • Probiotics are investigated for potential benefits in preventing and treating allergic diseases, especially in infants with atopic dermatitis (AD).
  • Previous studies suggest a possible therapeutic role for probiotics in managing sensitization and atopic conditions.

Purpose of the Study:

  • To assess the clinical and immunological impact of supplementing a hydrolyzed formula with two specific probiotic strains.
  • To evaluate the effects on the symptoms of atopic dermatitis in infants.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving infants under 5 months with AD.
  • Infants received a hydrolyzed whey formula with either Lactobacillus rhamnosus, Lactobacillus GG, or placebo for 3 months.
  • Clinical severity (SCORAD), allergic sensitization (IgE levels, skin prick tests), and inflammatory markers were assessed.

Main Results:

  • No statistically significant differences were observed in SCORAD, sensitization, or inflammatory parameters between the probiotic and placebo groups.
  • Cytokine production (IL-4, IL-5, IFN-gamma) also showed no significant changes.
  • Cow's milk allergy (CMA) was diagnosed in only four infants.

Conclusions:

  • The studied probiotic bacteria demonstrated no significant clinical or immunological effects in infants with atopic dermatitis.
  • Oral supplementation with these specific probiotic strains is unlikely to substantially impact infantile AD symptoms.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Acne Infection01:27

Acne Infection

Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...